External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
about
Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients.Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall StudyClinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patientsEvaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study.Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equationsAdiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus.Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients.Estimation of absolute cardiovascular risk in individuals with diabetes mellitus: rationale and approaches.Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trAdditive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine.Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination TherapyThe utility of carotid ultrasonography in identifying severe coronary artery disease in asymptomatic type 2 diabetic patients without history of coronary artery diseaseAssociation of Chronic Kidney Disease with Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus: An Observational Cross-sectional Study in Hangzhou, China.Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial.Statins and beyond: concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes.Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes.The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus.ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.A Point-based Mortality Prediction System for Older Adults with Diabetes.High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus.Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus.
P2860
Q30863970-0D8CC0F3-C749-4240-9F65-0D914F389DEFQ33628605-0FB1BE58-ABE3-4A59-8647-D277ABE723F9Q34218665-71084637-F7C5-48A6-96CB-05F9DD23DB64Q34233807-1351BA1F-E730-4771-AE8E-699E3CAD75EBQ34331209-80FC3E99-1C1E-4915-9A1B-C59D9D65FCF3Q34332236-521511A1-D04E-45DF-B781-237A0F52CF38Q34937824-3661CFDB-4EDC-473E-ABBE-0E21704F8506Q35179815-D0C87BFD-D5D5-45E1-ABAF-A4E0CF5EED51Q35684294-CB43EB6D-EED7-40C3-AD6A-BA80968E160BQ35688224-9241633B-405D-418C-9DD4-4DB1F56552C8Q35810520-F1BC5297-9C7B-4709-B171-2392E9791892Q36079398-72BDC1ED-26FD-4976-8E15-D6642539C977Q36360096-70D40613-966D-427C-B913-0BE51EEF49FFQ36782869-0CCC5D5C-E612-407E-9A3D-E9F05AD3419DQ37572421-6663FE03-BA6B-4AD8-A608-F09E65645E15Q37660835-340C6766-C171-40A4-8B2F-AF6511DFE52AQ38020453-2B383B6C-0B95-45A8-B7F0-CEC31B3B4A1FQ38073629-4FA00A6C-A288-4D71-9429-CEEEE8D10D12Q38254322-792A6832-209A-4900-AE28-9C9FCD1A3070Q40635839-FF889C64-AA63-4E2E-B899-3C757F724FE1Q42281548-FBB884EC-676F-4163-A44F-5FEE745C24AEQ44146770-95BAFABC-88B0-41FE-81E8-0499E3000739Q44536531-12069FD4-E78E-48CB-B60A-CCFBEB1AD564Q45906829-E97E3294-5001-4B51-A0A7-BF25884C0869Q48799668-1A00F5C6-CB4E-43DF-BA41-F0538DF99890
P2860
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
External validation of the UK ...... patients with type 2 diabetes
@ast
External validation of the UK ...... patients with type 2 diabetes
@en
External validation of the UK Prospective Diabetes Study
@nl
type
label
External validation of the UK ...... patients with type 2 diabetes
@ast
External validation of the UK ...... patients with type 2 diabetes
@en
External validation of the UK Prospective Diabetes Study
@nl
prefLabel
External validation of the UK ...... patients with type 2 diabetes
@ast
External validation of the UK ...... patients with type 2 diabetes
@en
External validation of the UK Prospective Diabetes Study
@nl
P2093
P2860
P50
P1433
P1476
External validation of the UK ...... patients with type 2 diabetes
@en
P2093
A M W Spijkerman
D L van der A
G E H M Rutten
J W J Beulens
K G M Moons
L M Peelen
S van Dieren
U Nöthlings
P2860
P2888
P304
P356
10.1007/S00125-010-1960-0
P577
2010-11-14T00:00:00Z
P5875
P6179
1030896469